Purification and characterization of a cytosolic phosphoinositide-phospholipase C (gamma 2-type) from human platelets. 1990

Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
Department of Biochemistry, Gifu University School of Medicine, Japan.

A human platelet cytosolic phosphoinositide-specific phospholipase C, one of four PLC activity peaks separated by column chromatographies, designated as cPLC-I, was purified to homogeneity. The cPLC-I exhibited an apparent Mr of 145 kDa by SDS-polyacrylamide gel electrophoresis and was immunologically identified to be PLC-gamma 2. It hydrolyzed PI and PIP2 at optimum pH of 5.5-6.0. Deoxycholate and cholate inhibited the enzyme activity to hydrolyze two substrates. Calcium was required to obtain the maximal activity for PI- and PIP2-hydrolysis at concentration of 10(-3) M and 10(-5) M, respectively. Hg2+ (1 microM) inhibited strongly the enzyme activity.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006882 Hydroxyapatites A group of compounds with the general formula M10(PO4)6(OH)2, where M is barium, strontium, or calcium. The compounds are the principal mineral in phosphorite deposits, biological tissue, human bones, and teeth. They are also used as an anticaking agent and polymer catalysts. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydroxyapatite Derivatives,Derivatives, Hydroxyapatite
D017886 Durapatite The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis. Calcium Hydroxyapatite,Hydroxyapatite,Hydroxylapatite,Alveograf,Calcitite,Interpore-200,Interpore-500,Osprovit,Ossein-Hydroxyapatite Compound,Ossopan,Osteogen,Periograf,Hydroxyapatite, Calcium,Interpore 200,Interpore 500,Interpore200,Interpore500,Ossein Hydroxyapatite Compound

Related Publications

Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
May 1987, The Biochemical journal,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
July 1990, The Biochemical journal,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
July 1986, The Biochemical journal,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
January 1992, Platelets,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
January 1991, Methods in enzymology,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
September 1982, Journal of biochemistry,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
August 1988, The Journal of biological chemistry,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
April 1986, Biochemical and biophysical research communications,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
November 1992, The Journal of biological chemistry,
Y Banno, and A Yu, and T Nakashima, and Y Homma, and T Takenawa, and Y Nozawa
August 2000, Journal of lipid research,
Copied contents to your clipboard!